We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GENX market cap is 2.96M. The company's latest EPS is CAD -0.0742 and P/E is -0.67.
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 137k | 0 | 0 | 0 | 12k |
Operating Income | -78k | -469k | -1.39M | -860k | -4.19M |
Net Income | -164k | -718k | -1.65M | -1.07M | -4.4M |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 40k | 5.35M | 4.77M | 4.25M | 223k |
Total Liabilities | 82k | 490k | 755k | 1.05M | 1.36M |
Total Equity | -42k | 4.86M | 4.01M | 3.2M | -1.14M |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -130k | -195k | -428k | -220k | -220k |
Investing | N/A | -8k | N/A | -3k | N/A |
Financing | 20k | 868k | -129k | 93k | 223k |
Market Cap | 2.96M |
Price to Earnings Ratio | -0.67 |
Price to Sales Ratio | 250 |
Price to Cash Ratio | 250 |
Price to Book Ratio | -2.6 |
Dividend Yield | - |
Shares Outstanding | 59.22M |
Average Volume (1 week) | 600 |
Average Volume (1 Month) | 3.46k |
52 Week Change | 66.67% |
52 Week High | 0.09 |
52 Week Low | 0.015 |
Spread (Intraday) | 0.01 (16.67%) |
Company Name | Genix Pharmaceuticals Corp |
Address |
10022 - 102 avenue grande prairie, alberta T8V 0Z7 |
Website | https://www.genixpharm.com |
Industry | food preparations, nec (2099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions